Praesidio Overview

  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc

Praesidio General Information


Owner and operator of a drug development company intended to develop drug for rare diseases. The company's services provide cell culture, molecular biology, and pharmacogenetics to develop novel drug screening methods, drugs and genetic testing assays, enabling physicians to develop and recommend diagnosing orphan diseases and providing personalized dosing of pharmaceutical drugs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Primary Office
  • 12085 Research Drive
  • Alachua, FL 32615
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Praesidio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view Praesidio’s complete valuation and funding history, request access »

Praesidio Executive Team (1)

Name Title Board Seat Contact Info
Richard Wagner Chief Executive Officer
To view Praesidio’s complete executive team members history, request access »